AI Image
Heart drug flops raise doubts about high-tech approaches to pharma
STAT • • business
Key Points:
- Despite high hopes, artificial intelligence and new technologies have not yet delivered cures for major diseases like heart attacks and strokes, the leading causes of death in developed countries.
- Pharmaceutical researchers have repeatedly found that technologies intended to accelerate drug development often fail to meet expectations.
- Two recent studies presented at the American Heart Association meeting highlight that advances in genetic understanding have not improved success rates in developing new treatments for cardiovascular diseases.
